Novartis Aktie

Novartis für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 907122 / ISIN: US66987V1098

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
13.11.2013 17:43:00

Grifols S.A. -- Moody's changes the outlook of Grifols' Ba2 rating to negative

Frankfurt am Main, November 13, 2013 -- Moody's Investors Service has today changed to negative from stable the outlook on Grifols S.A. ("Grifols" or "the company") ratings. Concurrently, the Ba2 Corporate Family Rating (CFR), the Ba2-PD Probability of Default Rating as well as the Ba1 senior secured and B1 senior unsecured ratings to bank and bond instruments respectively of Grifols and its guaranteed subsidiary have been affirmed. This rating action follows the announcement to acquire Novartis diagnostic business unit for US$1.675 billion.

Vollständigen Artikel bei Moodys lesen